BioCentury | Feb 3, 2017
Financial News

Biscayne Neurotherapeutics completes venture financing

...a series B round co-led by Quark Venture's Global Health Sciences Fund, GF Securities and Mesa Verde Venture Partners...
BioCentury | Dec 2, 2016
Financial News

Paradigm completes venture financing

...million in a first close of a planned $7 million series B round led by Mesa Verde Venture Partners...
BioCentury | Dec 23, 2013
Financial News

Lineagen completes venture financing

...12/18/13 Type: Venture financing Raised: $3.5 million Investors: Signal Peak Ventures; Sanderling; PrairieGold Venture Partners; Mesa Verde Venture Partners...
BioCentury | Sep 17, 2012
Financial News

Exagen completes venture financing

...Venture financing Raised: $5.3 million Investors: Tullis Health Investors; Sun Mountain Capital; Cottonwood Technology Fund; Mesa Verde Venture Partners...
BioCentury | Sep 3, 2012
Company News

Elevation Pharmaceuticals, Dainippon Sumitomo deal

...million from venture capital investors, including Canaan Partners; Novo Ventures; TPG Biotech; Care Capital; and Mesa Verde Venture Partners...
BioCentury | Aug 31, 2012
Company News

Sunovion to acquire Elevation

...million from venture capital investors, including Canaan Partners; Novo Ventures; TPG Biotech; Care Capital; and Mesa Verde Venture Partners...
BioCentury | Jan 9, 2012
Financial News

Elevation Pharmaceuticals completes venture financing

...Type: Venture financing Raised: $30 million Investors: Novo Ventures; Canaan Partners; TPG Biotech; Care Capital; Mesa Verde Venture Partners...
BioCentury | Jan 5, 2012
Financial News

Elevation raises $30M in series B

...All previous investors participated in the round, including Canaan Partners; TPG Biotech; Care Capital; and Mesa Verde Venture Partners...
BioCentury | Oct 3, 2011
Financial News

Elevation Pharmaceuticals financial update

...in the round to $30 million. Existing investors Canaan Partners; TPG Growth; Care Capital; and Mesa Verde Venture Partners...
BioCentury | Sep 27, 2011
Clinical News

COPD data show EP-101 improves FEV1 vs. placebo

...in the round to $30 million. Existing investors Canaan Partners; TPG Growth; Care Capital; and Mesa Verde Venture Partners...
Items per page:
1 - 10 of 15
BioCentury | Feb 3, 2017
Financial News

Biscayne Neurotherapeutics completes venture financing

...a series B round co-led by Quark Venture's Global Health Sciences Fund, GF Securities and Mesa Verde Venture Partners...
BioCentury | Dec 2, 2016
Financial News

Paradigm completes venture financing

...million in a first close of a planned $7 million series B round led by Mesa Verde Venture Partners...
BioCentury | Dec 23, 2013
Financial News

Lineagen completes venture financing

...12/18/13 Type: Venture financing Raised: $3.5 million Investors: Signal Peak Ventures; Sanderling; PrairieGold Venture Partners; Mesa Verde Venture Partners...
BioCentury | Sep 17, 2012
Financial News

Exagen completes venture financing

...Venture financing Raised: $5.3 million Investors: Tullis Health Investors; Sun Mountain Capital; Cottonwood Technology Fund; Mesa Verde Venture Partners...
BioCentury | Sep 3, 2012
Company News

Elevation Pharmaceuticals, Dainippon Sumitomo deal

...million from venture capital investors, including Canaan Partners; Novo Ventures; TPG Biotech; Care Capital; and Mesa Verde Venture Partners...
BioCentury | Aug 31, 2012
Company News

Sunovion to acquire Elevation

...million from venture capital investors, including Canaan Partners; Novo Ventures; TPG Biotech; Care Capital; and Mesa Verde Venture Partners...
BioCentury | Jan 9, 2012
Financial News

Elevation Pharmaceuticals completes venture financing

...Type: Venture financing Raised: $30 million Investors: Novo Ventures; Canaan Partners; TPG Biotech; Care Capital; Mesa Verde Venture Partners...
BioCentury | Jan 5, 2012
Financial News

Elevation raises $30M in series B

...All previous investors participated in the round, including Canaan Partners; TPG Biotech; Care Capital; and Mesa Verde Venture Partners...
BioCentury | Oct 3, 2011
Financial News

Elevation Pharmaceuticals financial update

...in the round to $30 million. Existing investors Canaan Partners; TPG Growth; Care Capital; and Mesa Verde Venture Partners...
BioCentury | Sep 27, 2011
Clinical News

COPD data show EP-101 improves FEV1 vs. placebo

...in the round to $30 million. Existing investors Canaan Partners; TPG Growth; Care Capital; and Mesa Verde Venture Partners...
Items per page:
1 - 10 of 15